Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Queensland Health
Merck
Citi
Accenture
Cerilliant
Boehringer Ingelheim
Federal Trade Commission

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 063179

« Back to Dashboard

NDA 063179 describes ERYTHROMYCIN STEARATE, which is a drug marketed by Ani Pharms Inc, Lederle, Mylan, Purepac Pharm, and Watson Labs, and is included in seven NDAs. Additional details are available on the ERYTHROMYCIN STEARATE profile page.

The generic ingredient in ERYTHROMYCIN STEARATE is erythromycin stearate. There are one hundred and two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 063179
Tradename:ERYTHROMYCIN STEARATE
Applicant:Ani Pharms Inc
Ingredient:erythromycin stearate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 500MG BASE
Approval Date:May 15, 1990TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Dow
Deloitte
Colorcon
Fish and Richardson
Farmers Insurance
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.